Expression of epithelial-mesenchymal transition regulators SNAI2 and TWIST1 in thyroid carcinomas

Modern Pathology

Volumn 26, Issue 1, 2013, Pages 54-61

  Buehler, Darya ^a   Hardin, Heather ^a   Shan, Weihua ^a   Montemayor Garcia, Celina ^a   Rush, Patrick S ^a   Asioli, Sofia ^b   Chen, Herbert ^a   Lloyd, Ricardo V ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

Anaplastic thyroid carcinoma; CDH1; SNAI2; thyroid carcinoma; thyroid cell lines; TWIST1

Indexed keywords

TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR TWIST; UVOMORULIN;

ADULT; ANAPLASTIC THYROID CANCER; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DISEASE ASSOCIATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; THYROID ADENOMA; THYROID CARCINOMA; THYROID CELL; THYROID FOLLICULAR CARCINOMA; TISSUE MICROARRAY; TUMOR DIFFERENTIATION; VALIDATION PROCESS;

EID: 84871928028     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2012.137     Document Type: Article

References (23)

1. Thiery JP, Acloque H, Huang RY, et al. Epithelialmesenchymaltransitions in development and disease.Cell 2009;139:871-890.
2. Hollier BG, Evans K, Mani SA. The epithelial-tomesenchymaltransition and cancer stem cells: acoalition against cancer therapies. J Mammary GlandBiol Neoplasia 2009;14:29-43.
3. Polyak K, Weinberg RA. Transitions between epithelialand mesenchymal states: acquisition of malignant andstem cell traits. Nat Rev Cancer 2009;9:265-273.
4. Peinado H, Olmeda D, Cano A. Snail, Zeb and bHLHfactors in tumour progression: an alliance against theepithelial phenotype? Nat Rev Cancer 2007;7:415-428. (Pubitemid 46809165)
5. Shioiri M, Shida T, Koda K, et al. Slug expression is anindependent prognostic parameter for poor survival incolorectal carcinoma patients. Br J Cancer 2006;94:1816-1822. (Pubitemid 43882571)
6. Hotz B, Arndt M, Dullat S, et al. Epithelial tomesenchymal transition: expression of the regulatorssnail, slug, and twist in pancreatic cancer. Clin CancerRes 2007;13:4769-4776. (Pubitemid 47294783)
7. Sarrio D, Rodriguez-Pinilla SM, Hardisson D, et al.Epithelial-mesenchymal transition in breast cancer relatesto the basal-like phenotype. Cancer Res 2008;68:989-997. (Pubitemid 351272216)
8. Ansieau S, Morel AP, Hinkal G, et al. TWISTing anembryonic transcription factor into an oncoprotein.Oncogene 2010;29:3173-3184.
9. Mikami S, Katsube K, Oya M, et al. Expression of Snailand Slug in renal cell carcinoma: E-cadherin repressorSnail is associated with cancer invasion and prognosis.Lab Invest 2011;91:1443-1458.
10. Vasko V, Espinosa AV, Scouten W, et al. Gene expressionand functional evidence of epithelial-to-mesenchymaltransition in papillary thyroid carcinoma invasion.Proc Natl Acad Sci USA 2007;104:2803-2808. (Pubitemid 46327960)
11. Kebebew E, Greenspan FS, Clark OH, et al. Anaplasticthyroid carcinoma. Treatment outcome and prognosticfactors. Cancer 2005;103:1330-1335. (Pubitemid 40410726)
12. Wiseman SM, Masoudi H, Niblock P, et al. Derangementof the E-cadherin/catenin complex is involved intransformation of differentiated to anaplastic thyroidcarcinoma. Am J Surg 2006;191:581-587.
13. Aratake Y, Nomura H, Kotani T, et al. Coexistentanaplastic and differentiated thyroid carcinoma: animmunohistochemical study. Am J Clin Pathol2006;125:399-406. (Pubitemid 43327709)
14. Braun J, Hoang-Vu C, Dralle H, et al. Downregulationof microRNAs directs the EMT and invasive potentialof anaplastic thyroid carcinomas. Oncogene 2010;29:4237-4244.
15. Knauf JA, Sartor MA, Medvedovic M, et al. Progressionof BRAF-induced thyroid cancer is associated withepithelial-mesenchymal transition requiring concomitantMAP kinase and TGFbeta signaling. Oncogene2011;30:3153-3162.
16. Salerno P, Garcia-Rostan G, Piccinin S, et al. TWIST1plays a pleiotropic role in determining the anaplasticthyroid cancer phenotype. J Clin Endocrinol Metab2011;96:E772-E781.
17. Hardy RG, Vicente-Duenas C, Gonzalez-Herrero I, et al.Snail family transcription factors are implicatedin thyroid carcinogenesis. Am J Pathol 2007;171:1037-1046. (Pubitemid 47441000)
18. R Development Core Team R: A Language andEnvironment for Statistical Computing. R Foundationfor Statistical Computing: Vienna, Austria, 2011.
19. Riesco-Eizaguirre G, Rodriguez I, De la Vieja A, et al.The BRAFV600E oncogene induces transforminggrowth factor beta secretion leading to sodium iodidesymporter repression and increased malignancy inthyroid cancer. Cancer Res 2009;69:8317-8325.
20. Zito G, Richiusa P, Bommarito A, et al. In vitroidentification and characterization of CD133(pos)cancer stem-like cells in anaplastic thyroid carcinomacell lines. PLoS One 2008;3:e3544.
21. Friedman S, Lu M, Schultz A, et al. CD133\+anaplastic thyroid cancer cells initiate tumors inimmunodeficient mice and are regulated by thyrotropin.PLoS One 2009;4:e5395.
22. Liu J, Brown RE. Immunohistochemical detection ofepithelialmesenchymal transition associated withstemness phenotype in anaplastic thyroid carcinoma.Int J Clin Exp Pathol 2010;3:755-762.
23. Sung CO, Lee KW, Han S, et al. Twist1 is up-regulatedin gastric cancer-associated fibroblasts with poorclinical outcomes. Am J Pathol 2011;179:1827-1838.